Improved Retinal Ganglion Cell Survival through Retinal Microglia Suppression by a Chinese Herb Extract, Triptolide, in the DBA/2J Mouse Model of Glaucoma

被引:15
作者
Yang, Fan [1 ]
Wu, Lingling [1 ]
Guo, Xiujuan [1 ]
Wang, Dongmei [1 ]
Li, Ying [1 ]
机构
[1] Peking Univ, Hosp 3, Beijing 100871, Peoples R China
关键词
DBA/2J mouse; glaucoma; microglia; neuroprotection; triptolide; PROTECTS DOPAMINERGIC-NEURONS; INFLAMMATION-MEDIATED DAMAGE; NECROSIS-FACTOR-ALPHA; TNF-ALPHA; INTRAOCULAR-PRESSURE; ACTIVATED MICROGLIA; RESPONSES; MICE; NEURODEGENERATION; NEUROPROTECTION;
D O I
10.3109/09273948.2013.806989
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To investigate the changes in retinal microglia and retinal ganglion cell (RGC) survival after long-term administration of a Chinese herb extract, triptolide, in a DBA/2J mice. DBA/2J mice (n = 96) were administered triptolide (n = 48) 25 mg/kg or vehicle (n = 48) and were judged at 7, 9, 11 months of age. Long-term triptolide treatment tended to attenuate the anterior segment pathology in experimental group, though intraocular pressure was not significantly different between the two groups. In the experimental group, RGC survival was improved (7, 9, 11 months: p = 0.035, 0.004, 0.014), and microglia activation was suppressed based on a more ramified appearance (9, 11 months: p = 0.024, 0.013) and a lower total microglial cell count (7, 9, 11 months: p = 0.028, 0.025, 0.014). Double-immunofluorescence staining revealed TNF? localized to microglia, TNFR1 localized to the RGCs and nerve fiber layer. These findings indicate that long-term triptolide administration suppressed microglia activation and improved RGC survival in DBA/2J mice.
引用
收藏
页码:378 / 389
页数:12
相关论文
共 56 条
  • [1] Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo
    Antonoff, Mara B.
    Chugh, Rohit
    Borja-Cacho, Daniel
    Dudeja, Vikas
    Clawson, Kimberly A.
    Skube, Steven J.
    Sorenson, Brent S.
    Saltzman, Daniel A.
    Vickers, Selwyn M.
    Saluja, Ashok K.
    [J]. SURGERY, 2009, 146 (02) : 282 - 290
  • [2] Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
    Block, Michelle L.
    Zecca, Luigi
    Hong, Jau-Shyong
    [J]. NATURE REVIEWS NEUROSCIENCE, 2007, 8 (01) : 57 - 69
  • [3] Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma
    Bosco, Alejandra
    Inman, Denise M.
    Steele, Michael R.
    Wu, Guangming
    Soto, Ileana
    Marsh-Armstrong, Nicholas
    Hubbard, Walter C.
    Calkins, David J.
    Horner, Philip J.
    Vetter, Monica L.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (04) : 1437 - 1446
  • [4] Early Microglia Activation in a Mouse Model of Chronic Glaucoma
    Bosco, Alejandra
    Steele, Michael R.
    Vetter, Monica L.
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2011, 519 (04) : 599 - 620
  • [5] Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae)
    Brinker, Anita M.
    Ma, Jun
    Lipsky, Peter E.
    Raskin, Ilya
    [J]. PHYTOCHEMISTRY, 2007, 68 (06) : 732 - 766
  • [6] Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F
    Chen, BJ
    [J]. LEUKEMIA & LYMPHOMA, 2001, 42 (03) : 253 - 265
  • [7] The effects of triptolide on airway remodelling and transforming growth factor-β1/Smad signalling pathway in ovalbumin-sensitized mice
    Chen, Ming
    Lv, Zhiqiang
    Jiang, Shanping
    [J]. IMMUNOLOGY, 2011, 132 (03) : 376 - 384
  • [8] Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
    Chen, X
    Murakami, T
    Oppenheim, JJ
    Howard, OMZ
    [J]. BLOOD, 2005, 106 (07) : 2409 - 2416
  • [9] Microglia and neurodegeneration: The role of systemic inflammation
    Cunningham, Colm
    [J]. GLIA, 2013, 61 (01) : 71 - 90
  • [10] Neuroprotection in glaucoma: recent and future directions
    Danesh-Meyer, Helen V.
    [J]. CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (02) : 78 - 86